Scientists from the Florida campus of The Scripps Research Institute (TSRI) have successfully tested a potent synthetic compound that prevents type 1
diabetes in animal models of the disease.
Not exact matches
In collaboration with the United States Department of Agriculture (USDA), researchers in the UPV / EHU's «Nutrition and Obesity» Group, which belongs to the Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERobn) of the Carlos III Institute of Health, have observed in animal models that its administration reduces the build - up of body fat, which could reduce the risk of developing other diseases like diabete
In collaboration with the United States Department
of Agriculture (USDA), researchers
in the UPV / EHU's «Nutrition and Obesity» Group, which belongs to the Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERobn) of the Carlos III Institute of Health, have observed in animal models that its administration reduces the build - up of body fat, which could reduce the risk of developing other diseases like diabete
in the UPV / EHU's «Nutrition and Obesity» Group, which belongs to the Spanish Biomedical Research Centre
in Physiopathology of Obesity and Nutrition (CIBERobn) of the Carlos III Institute of Health, have observed in animal models that its administration reduces the build - up of body fat, which could reduce the risk of developing other diseases like diabete
in Physiopathology
of Obesity and Nutrition (CIBERobn)
of the Carlos III Institute
of Health, have observed
in animal models that its administration reduces the build - up of body fat, which could reduce the risk of developing other diseases like diabete
in animal models that its administration reduces the build - up
of body fat, which could reduce the risk
of developing other
diseases like
diabetes.
In animal models of disease, iPSCs have been used to treat sickle cell anemia, Parkinson's
disease,
diabetes, spinal cord injuries, and heart failure.
General Product Information Obesity - High Fat Diets for Diet - Induced Obesity
Models Metabolic Syndrome - Diet - Induced Metabolic Syndrome
in Rodent
Models Diabetes - High Fructose / Sucrose Diets for inducing Hypertriglyceridemia and Insulin Resistance
in Rodents Atherosclerosis - Diet - Induced Atherosclerosis / Hypercholesterolemia
in Rodent
Models Hypertension - Phenotypic Expression
of Hypertension
in Rodent
Models through Dietary Manipulation NAFLD (Non-alcoholic Fatty Liver
Disease) Cancer - Creating a Clean Background for Oncology Research Test Compounds / Kaolin Pellets Diet and Immunology Focus: Arsenic
in Grain - Based Laboratory
Animal Diets and Effects on the Rodent Toxicological Phenotype Focus: The Importance
of a Proper Control Diet
Among the newly funded investigations are: the development
of animal models of diabetic eye
disease to learn how fenofibrate, a drug clinically - approved to treat cholesterol, protects the eye from
diabetes - related damage; the development
of a specialized camera to capture how the retina's rods and cones (responsible for turning light energy into shapes and colors) work
in health and how they fail
in retinal
diseases; and the exploration
of mechanisms by which intestinal tract bacteria impact the health
of the eye.
This proposed role for GM1 (and indirectly GD1a) provides a rationale for its potency
in suppressing
diabetes in NOD mice (10) and
disease onset
in other
animal models of autoimmunity.